Amalgamated Financial’s Arcellx ACLX Stock Holding History

Amalgamated Financial’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$31K	Buy	+2,229	New	+$37.3K	﹤0.01%	2606

Other funds holding ACLX

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Amalgamated Financial's ACLX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Arcellx (ACLX) in Q1 2022: 2,229 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #2606 among its holdings.

49 funds tracked by Wall St. Rank hold ACLX as of Q1 2022.

Amalgamated Financial held 2,229 shares of Arcellx worth $31K as of Q1 2022.
Arcellx was a new Amalgamated Financial position in Q1 2022.
Arcellx made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2606 holding.
49 funds tracked by Wall St. Rank held Arcellx as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.